Home > PS Ratio > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
PS (Price/Sales) Ratio

The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 5.25.

Share Price ₹105.3Jun 09,2025
Market Cap ₹227.4 Cr
Sales-TTM₹43.3 CrTTM-Standalone Results
Price/Sales5.25xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results
KREBS BIOCHEMICALS & INDUSTRIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of KREBS BIOCHEMICALS & INDUSTRIES is calculated as :

Current Market Cap [ ₹227.4 Cr] as on Jun 09,2025

(/) Sales [ ₹43.3 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 5.25x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '5.25 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !

The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.

Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES


PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES

- KREBS BIOCHEMICALS & INDUSTRIES 's latest p/e ratio is 5.25x.

- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.56x.

- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.

- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.


How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
KREBS BIOCHEMICALS & INDUSTRIES 43.35.25227.4
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.73406,519.0
DIVIS LABORATORIES LTD9,360.018.79175,903.0
CIPLA LTD27,547.64.42121,669.0
TORRENT PHARMACEUTICALS LTD11,516.09.34107,605.0
DR REDDYS LABORATORIES LTD32,643.93.37110,097.0
MANKIND PHARMA LTD12,279.37.9297,239.7
ZYDUS LIFESCIENCES LTD23,241.54.2197,951.9
LUPIN LTD22,707.94.0191,051.4
AUROBINDO PHARMA LTD31,723.72.1367,457.2
ABBOTT INDIA LTD6,409.210.5567,600.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.13x
Max industry PS 18.79x
Median industry PS 5.25x
Average industry PS 7.07x



You may also like the below Video Courses